financetom
Business
financetom
/
Business
/
Trinseo Insider Bought Shares Worth $452,534, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trinseo Insider Bought Shares Worth $452,534, According to a Recent SEC Filing
Aug 20, 2024 7:49 AM

10:28 AM EDT, 08/20/2024 (MT Newswires) -- Jeffrey J Cote, Director, on August 16, 2024, executed a purchase for 150,600 shares in Trinseo ( TSE ) for $452,534. Following the Form 4 filing with the SEC, Cote has control over a total of 226,512 shares of the company, with 75,912 shares held directly and 150,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1519061/000141588924021666/xslF345X03/form4-08202024_020809.xml

Price: 3.48, Change: +0.17, Percent Change: +5.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Americas Gold and Silver to Be Added to Solactive Global Silver Miners Index
Americas Gold and Silver to Be Added to Solactive Global Silver Miners Index
May 25, 2025
12:14 PM EDT, 04/28/2025 (MT Newswires) -- Americas Gold and Silver ( USAS ) said Monday it will be included in the Solactive Global Silver Miners Index, effective Thursday. Inclusion in the silver index can attract more institutional investment into the company and boost liquidity, Chairman and Chief Executive Officer Paul Huet said. Price: 0.61, Change: +0.01, Percent Change: +0.99...
Castle Biosciences' DecisionDx-Melanoma Test Orders Reach 200,000
Castle Biosciences' DecisionDx-Melanoma Test Orders Reach 200,000
May 25, 2025
12:09 PM EDT, 04/28/2025 (MT Newswires) -- Castle Biosciences ( CSTL ) said Monday its DecisionDx-Melanoma clinical test for patients with cutaneous melanoma reached 200,000 orders. The 31-gene expression profile test offers personalized results detailing a patient's predicted risk of recurrence or metastasis, the company said. Shares were down 2.8% in recent trading. Price: 20.05, Change: -0.58, Percent Change: -2.84...
ImmunityBio's Bladder Cancer Treatment Shows High Cystectomy Avoidance, Long-Term Response
ImmunityBio's Bladder Cancer Treatment Shows High Cystectomy Avoidance, Long-Term Response
May 25, 2025
12:09 PM EDT, 04/28/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Monday its phase 2/3 trial of Anktiva plus Bacillus Calmette-Guerin in adults with BCG-unresponsive non-muscle invasive bladder cancer, with or without papillary disease, showed prolonged complete response and a relatively higher rate of cystectomy avoidance. The trial results, presented at the American Urological Association Annual Meeting in Las...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved